Ian Jones

Ian specialises in the pharmaceutical and medical sectors, where he collaborates with clients developing cutting-edge treatments for conditions ranging from cancer, ALS/MND, and Parkinson’s disease, to dermatitis and anti-aging technologies. He also possesses extensive experience in the biotechnology and industrial chemical industries, particularly in home and personal care products, as well as functional polymers. With a focus on IP strategy and prosecution, backed by a strong portfolio in EPO oppositions and appeals, Ian advises clients on maximising the value of intellectual property to support their business goals and enhance revenue across the full lifecycle of their products.

In the pharmaceutical field, Ian primarily works with new chemical entities, including those developed through artificial intelligence (AI), drug repurposing, and formulation of dosage regimens. He is also a leading authority on Supplementary Protection Certificates (SPCs), helping clients maintain market share beyond patent expiration.

While Ian’s core client base consists of UK-based medium-sized enterprises, he works with a broad spectrum of companies. From assisting start-ups with IP fundamentals to providing clear and actionable advice to multinational corporations, Ian delivers expert guidance tailored to each client’s needs.

Ian deals with a broad range of technologies, and specialises in:

• New chemical entities in the pharmaceutical sector, particularly derived from artificial intelligence
• Drug repositioning/repurposing, formulations and dosage regimens
• Process chemistry, home and personal care products, and polymers
• Supplementary Protection Certificate (SPC) and patent term extensions
• Hosting innovation capture sessions to identify and harvest patentable products
• Conducting patent landscaping and Freedom-to-Operate analysis to minimise third-party IP risk
• Patent portfolio and asset management
• Devising and implementing patent evergreening strategies to extend product lifecycle and maximise product revenue
• Conducting due diligence on behalf of investors to audit and evaluate IP, including patent-product mapping

European Patent Attorney
UK Patent Attorney
UPC Representative

Intellectual Property Litigation Certificate
Fellow of the Chartered Institute of Patent Attorneys (CIPA)
Member of the European Patent Institute (EPI)

After graduating from University of Cardiff with a First Class (Hons) Master’s Degree in Chemistry, Ian obtained a PhD in organic chemistry from the same institute. He also has a Postgraduate Diploma in Intellectual Property Law from University of Manchester.

Ian joined the patent profession in 2012, after a successful career in pharmaceutical research. He gained experience at other top tier UK firms before joining GJE 2016, and joining the partnership in 2022.